621 related articles for article (PubMed ID: 30614823)
1. Beneficial effect of ticagrelor on microvascular perfusion in patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Wang X; Li X; Wu H; Li R; Liu H; Wang L; Bai S; Zhang L; Chen T; Liu J; Li Q; Du R
Coron Artery Dis; 2019 Aug; 30(5):317-322. PubMed ID: 30614823
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
3. Switching from ticagrelor to clopidogrel in patients with ST-segment elevation myocardial infarction undergoing successful percutaneous coronary intervention in real-world China: Occurrences, reasons, and long-term clinical outcomes.
Li XY; Su GH; Wang GX; Hu HY; Fan CJ
Clin Cardiol; 2018 Nov; 41(11):1446-1454. PubMed ID: 30225843
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Microvascular Injury in Revascularized Patients With ST-Segment-Elevation Myocardial Infarction Treated With Ticagrelor Versus Prasugrel.
van Leeuwen MAH; van der Hoeven NW; Janssens GN; Everaars H; Nap A; Lemkes JS; de Waard GA; van de Ven PM; van Rossum AC; Ten Cate TJF; Piek JJ; von Birgelen C; Escaned J; Valgimigli M; Diletti R; Riksen NP; van Mieghem NM; Nijveldt R; van Royen N
Circulation; 2019 Jan; 139(5):636-646. PubMed ID: 30586720
[TBL] [Abstract][Full Text] [Related]
6. No Benefit of Ticagrelor Pretreatment Compared With Treatment During Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Koul S; Smith JG; Götberg M; Omerovic E; Alfredsson J; Venetsanos D; Persson J; Jensen J; Lagerqvist B; Redfors B; James S; Erlinge D
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005528. PubMed ID: 29870381
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary administration of different doses of anisodamine in primary percutaneous coronary intervention: protective effect in patients with ST-segment elevation myocardial infarction.
Bai S; Fu X; Gu X; Wang Y; Li W; Fan Y; Wei L; Bi X
Coron Artery Dis; 2016 Jun; 27(4):302-10. PubMed ID: 26945186
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Abdelaziz HK; Elkilany W; Khalid S; Sabet S; Saad M
Coron Artery Dis; 2017 Jan; 28(1):11-16. PubMed ID: 27556348
[TBL] [Abstract][Full Text] [Related]
9. Effect of prasugrel versus ticagrelor on coronary microcirculation in patients undergoing pharmacoinvasive strategy - acute and short-term results.
Agrawal RS; Yusuf J; Mahajan B; Mehta V; Mandal S; Mukhopadhyay S
Coron Artery Dis; 2023 Sep; 34(6):381-388. PubMed ID: 37471285
[TBL] [Abstract][Full Text] [Related]
10. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
Montalescot G; van 't Hof AW; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Collet JP; Goodman SG; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Licour M; Merkely B; Salhi N; Silvain J; Storey RF; Ten Berg JM; Tsatsaris A; Zeymer U; Vicaut E; Hamm CW;
JACC Cardiovasc Interv; 2016 Apr; 9(7):646-56. PubMed ID: 26952907
[TBL] [Abstract][Full Text] [Related]
11. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
[TBL] [Abstract][Full Text] [Related]
12. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study.
Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
Int J Cardiovasc Imaging; 2020 Jun; 36(6):1121-1132. PubMed ID: 32078096
[TBL] [Abstract][Full Text] [Related]
13. Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial.
Fabris E; Van't Hof A; Hamm CW; Lapostolle F; Lassen JF; Goodman SG; Ten Berg JM; Bolognese L; Cequier A; Chettibi M; Hammett CJ; Huber K; Janzon M; Merkely B; Storey RF; Zeymer U; Cantor WJ; Kerneis M; Diallo A; Vicaut E; Montalescot G;
Catheter Cardiovasc Interv; 2019 Jun; 93(7):E369-E377. PubMed ID: 30302940
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of intracoronary versus intravenous high-dose bolus administration of tirofiban in diabetic patients undergoing primary percutaneous coronary intervention.
Ghonim AA; Mostafa A; Emara A; Algazzar AS; Qutub MA
Cardiovasc J Afr; 2019 Sep/Oct 23; 30(5):285-289. PubMed ID: 31194213
[TBL] [Abstract][Full Text] [Related]
15. Angiographic outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes).
Kunadian V; James SK; Wojdyla DM; Zorkun C; Wu J; Storey RF; Steg PG; Katus H; Emanuelsson H; Horrow J; Maya J; Wallentin L; Harrington RA; Gibson CM
JACC Cardiovasc Interv; 2013 Jul; 6(7):671-83. PubMed ID: 23866179
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
17. Therapy with ticagrelor for ST-elevated acute coronary syndrome accompanied by diabetes mellitus.
Liu Y; Ding LY; Li XZ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):312-318. PubMed ID: 31389599
[TBL] [Abstract][Full Text] [Related]
18. Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis.
Dai W; Ye Z; Li L; Su Q
Drug Des Devel Ther; 2018; 12():2039-2049. PubMed ID: 30013323
[TBL] [Abstract][Full Text] [Related]
19. Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial.
Degrauwe S; Roffi M; Lauriers N; Muller O; Masci PG; Valgimigli M; Iglesias JF
Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):158-163. PubMed ID: 30101278
[TBL] [Abstract][Full Text] [Related]
20. Event-Free Survival Following Successful Percutaneous Intervention in Acute Myocardial Infarction Depends on Microvascular Perfusion.
Xie F; Qian L; Goldsweig A; Xu D; Porter TR
Circ Cardiovasc Imaging; 2020 Jun; 13(6):e010091. PubMed ID: 32527159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
